Controlling chronic TTP

Blood

Volumn 106, Issue 6, 2005, Pages 1896-

  George, James N ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISINTEGRIN; GLUCOCORTICOID; RITUXIMAB; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

AUTOIMMUNE DISEASE; CHOLECYSTECTOMY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; RISK BENEFIT ANALYSIS; SPLENECTOMY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 24744458605     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-06-2535     Document Type: Review

References (3)

1. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. New Engl J Med. 1991;325:393-397.
2. Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thormbocytopenic purpura. In: Broudy VC, Berliner N, Larson RA, Leung LLK, eds. Hematology 2004. Washington, DC: American Society of Hematology; 2004:407-423.
3. Confer SD, Perdue JJ, Doan JT, George JN. TTP: the patient's perspective: Emily's story, http://moon.ouhsc. edu/jgeorge/emily.htm. Accessed July 12, 2005.